Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The picture is complicated by several confounding factors: Weight loss itself is associated with improved mood and reduced depressive symptoms in many individuals Better glycaemic control may enhance overall wellbeing and reduce diabetes-related distress Selection bias may exist, as patients with severe mental health conditions might be less likely to be prescribed these medications initially Currently, there is no official indication for GLP-1 agonists in treating depression, and the MHRA has not licensed these medications for mental health conditions
The GLP-1 app addresses this by consolidating injection timing, protein intake, water consumption, meals, and side-effect tracking in a single interface, helping patients identify response patterns and optimize their treatment approach
It has not been associated with the more serious potential complications of pharmaceutical GLP-1 agonists, such as pancreatitis or gallbladder problems
Unrealistic body image ideals and societal pressure
US$ 22.27
US$ 25.71
US$ 23.15
